Market open
Ventas/$VTR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Ventas
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Ticker
$VTR
Sector
Trading on
NYSE
Industry
Health Care REITs
Headquarters
Employees
486
Website
Ventas Metrics
BasicAdvanced
$27B
Market cap
-
P/E ratio
-$0.16
EPS
1.39
Beta
$1.80
Dividend rate
2.81%
Dividend yield
Price and volume
Market cap
$27B
Beta
1.39
52-week high
$65.81
52-week low
$41.45
Average daily volume
2.4M
Dividend rate
$1.80
Financial strength
Current ratio
1.074
Quick ratio
0.871
Long term debt to equity
136.679
Total debt to equity
136.679
Interest coverage (TTM)
1.15%
Management effectiveness
Return on assets (TTM)
1.73%
Return on equity (TTM)
-0.54%
Valuation
Price to revenue (TTM)
5.443
Price to book
2.75
Price to tangible book (TTM)
3.17
Price to free cash flow (TTM)
27.717
Dividend yield (TTM)
2.81%
Forward dividend yield
2.81%
Growth
Revenue change (TTM)
9.28%
Earnings per share change (TTM)
-1,658.99%
3-year revenue growth (CAGR)
8.20%
3-year earnings per share growth (CAGR)
-32.41%
What the Analysts think about Ventas
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Ventas stock.
Ventas Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Ventas Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Ventas News
AllArticlesVideos
Ventas Earns Nareit 2024 Healthcare “Leader in the Light” Award
Business Wire·18 hours ago
Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference
Business Wire·6 days ago
Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock
Business Wire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Ventas stock?
Ventas (VTR) has a market cap of $27B as of November 21, 2024.
What is the P/E ratio for Ventas stock?
The price to earnings (P/E) ratio for Ventas (VTR) stock is 0 as of November 21, 2024.
Does Ventas stock pay dividends?
Yes, the Ventas (VTR) stock pays dividends to shareholders. As of November 21, 2024, the dividend rate is $1.8 and the yield is 2.81%. Ventas has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Ventas dividend payment date?
The next Ventas (VTR) dividend payment date is unconfirmed.
What is the beta indicator for Ventas?
Ventas (VTR) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.